Our group has investigated a series of Nef peptides as agents to induce tumor cells apoptosis [12–16, 52] We have developed peptides from the secretion modification region (SMR) of HIV-1 Nef as a promising source of effective, less toxic new anticancer drugs. The gene discussed is S100B; the disease is neoplasm.